BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 19707983)

  • 41. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
    Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
    Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
    Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques.
    Paparella D; Galeone A; Venneri MT; Coviello M; Scrascia G; Marraudino N; Quaranta M; de Luca Tupputi Schinosa L; Brister SJ
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):290-7. PubMed ID: 16434256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of physical exercise training on graft patency after aortocoronary bypass grafting].
    Kubo H; Ohshima H; Hirai H; Yabuki S; Machii K; Sato K; Ebine K
    J Cardiol; 1993; 23(4):319-27. PubMed ID: 8064580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kallikrein-kinin system activation and its interactions with other plasma haemostatic components in the coronary artery disease.
    Czokało-Plichta M; Skibinska E; Kosiorek P; Musiał WJ
    Rocz Akad Med Bialymst; 2001; 46():209-24. PubMed ID: 11780565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit.
    Paola Cellai A; Antonucci E; Alessandrello Liotta A; Fedi S; Marcucci R; Falciani M; Giglioli C; Abbate R; Prisco D
    Thromb Res; 2006; 118(4):495-500. PubMed ID: 16318869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
    Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
    Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
    Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of very strong association between pre-treatment fibrinogen and PAI-1 with long-term mortality after coronary bypass surgery.
    Sjöland H; Tengborn L; Stensdotter L; Herlitz J
    Cardiology; 2007; 108(2):82-9. PubMed ID: 17008796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease.
    Oldgren J; Fellenius C; Boman K; Jansson JH; Nilsson TK; Wallentin L; Siegbahn A
    J Intern Med; 2005 Nov; 258(5):420-7. PubMed ID: 16238677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease.
    Brugts JJ; den Uil CA; Danser AH; Boersma E
    Cardiology; 2009; 112(4):303-12. PubMed ID: 18832826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.